Anxiety Disorder Clinical Trial
Official title:
A Double-Blind, Placebo Controlled Trial of an Experimental Medication For the Treatment of Generalized Anxiety Disorder
Verified date | October 2014 |
Source | Jazz Pharmaceuticals |
Contact | n/a |
Is FDA regulated | No |
Health authority | United States: Food and Drug Administration |
Study type | Interventional |
The purpose of this study is to determine whether an experimental anti-anxiety medication is effective in the treatment of Generalized Anxiety Disorder.
Status | Completed |
Enrollment | 511 |
Est. completion date | December 2005 |
Est. primary completion date | |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years to 65 Years |
Eligibility |
Inclusion Criteria: - Subjects 18 to 65 years of age will be eligible to participate if they satisfy the DSM-IV-TR criteria for the diagnosis of GAD. Exclusion Criteria: - No other primary psychiatric diagnosis besides GAD. |
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
United States | Crest Clinical Trials, Inc. | Anaheim | California |
United States | FutureSearch Trials | Austin | Texas |
United States | Pharmasite Research, Inc. | Baltimore | Maryland |
United States | Northwest Clinical Research Center | Bellevue | Washington |
United States | McLean Hospital | Belmont | Massachusetts |
United States | Southwesten Research, Inc. | Beverly Hills | California |
United States | Birmingham Research Group, Inc. | Birmingham | Alabama |
United States | Radiant Research | Boise | Idaho |
United States | Alpine Clinical Research Center | Boulder | Colorado |
United States | Florida Clinical Research Center | Bradenton | Florida |
United States | Social Psychiatry Research Institute | Brooklyn | New York |
United States | Southwestern Research Institute | Burbank | California |
United States | Southeast Health Consultants, LLC | Charleston | South Carolina |
United States | CNS Research Institute (CRI) | Clementon | New Jersey |
United States | Research Across America | Dallas | Texas |
United States | Midwest Clinical Research Center | Dayton | Ohio |
United States | ACT Clinical Research | DeLand | Florida |
United States | University Clinical Research DeLand, Inc. | DeLand | Florida |
United States | Oregon Center for Clinical Investigations, Inc. | Eugene | Oregon |
United States | Comprehensive Neuroscience of Northern Virginia | Falls Church | Virginia |
United States | Sarkis Clinical Trials | Gainsville | Florida |
United States | Clinical Neuroscience Solutions, Inc. | Jacksonville | Florida |
United States | ClinSearch, Inc. | Kenilworth | New Jersey |
United States | R/D Clinical Research, Inc. | Lake Jackson | Texas |
United States | Atlanta Institute of Medicine and Research | Marietta | Georgia |
United States | Suburban Research Associates | Media | Pennsylvania |
United States | CNS, Inc. | Memphis | Tennessee |
United States | New Orlean Medical Institute | Metairie | Louisiana |
United States | Dominion Clinical Research, Inc. | Midlothian, | Virginia |
United States | Clinical Research Associates, Inc. | Nashville | Tennessee |
United States | New Britain General Hospital | New Britain | Connecticut |
United States | American Medical Research, Inc. | Oak Brook | Illinois |
United States | IPS Research Company | Oklahoma City | Oklahoma |
United States | Clinical Neuroscience Solutions, Inc. | Orlando | Florida |
United States | Peak Medical Research, LLC | Owensboro | Kentucky |
United States | CNS Research Institute | Philadelphia | Pennsylvania |
United States | Princeton Medical Institute | Princeton | New Jersey |
United States | Pivotal Research Centers - Detroit | Royal Oak | Michigan |
United States | Lifetree Clinical Research | Salt Lake City | Utah |
United States | University of California - San Diego - Dept of Psychiatry | San Diego | California |
United States | Clinical Innovations | Santa Ana | California |
United States | Brentwood Research Institute | Shreveport | Louisiana |
United States | MedClin Research | St. Louis | Missouri |
United States | Meridien Research | St. Petersburg | Florida |
United States | Stanford University Medical Center | Stanford | California |
United States | Institute of Research in Psychiatry | Tampa | Florida |
United States | Neurology and Neuroscience Center of Ohio | Toledo | Ohio |
United States | Laureate Psychiatric Clinic and Hospital | Tulsa | Oklahoma |
United States | Diablo Clinical Research, Inc. | Walnut Creek | California |
United States | Janus Center for Psychiatric Research | West Palm Beach | Florida |
Lead Sponsor | Collaborator |
---|---|
Jazz Pharmaceuticals |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change in HAM-A Total Score | Hamilton Anxiety Rating Scale (HAM-A). Each of 14 symptoms categories is rated from 0=not present to 4=very severe. Numbers for all categories are summed to produce the total score. Total score ranges from 0=anxiety symptoms not present to 56=very severe anxiety symptoms across all 14 categories. | Baseline to week 8 | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06038721 -
Unified Protocol: Community Connections
|
N/A | |
Not yet recruiting |
NCT03224845 -
Courageous Parents, Courageous Children
|
N/A | |
Completed |
NCT02096783 -
Scripted Sexual Health Informational Intervention in Improving Sexual Function in Patients With Gynecologic Cancer
|
N/A | |
Completed |
NCT02145429 -
Preventing Depression in Late Life: A Model for Low and Middle Income Countries
|
N/A | |
Completed |
NCT00794456 -
Association of Passiflora Incarnata L; Crataegus Oxyacantha L and Salix Alba L. on Mild and Moderate Anxiety
|
Phase 3 | |
Terminated |
NCT00896467 -
Psychological and Emotional Impact in Patients Undergoing Treatment For Metastatic Cancer Either in a Clinical Trial or as Standard Off-Trial Therapy
|
N/A | |
Completed |
NCT00252343 -
Efficacy and Safety of SR58611A in Patients With a Generalized Anxiety Disorder
|
Phase 3 | |
Not yet recruiting |
NCT05867823 -
OcupApp: Occupational Self-analysis Intervention Through an Mobile Application
|
N/A | |
Recruiting |
NCT04562324 -
Efficacy of Electroencephalography (EEG) Neurofeedback (NF) for the Treatment of Anxiety Disorder
|
N/A | |
Recruiting |
NCT05989451 -
Adaptation of Individual Dialectical Behavior Therapy Intervention for Transdiagnostic Treatment of Emotional Disorders
|
N/A | |
Not yet recruiting |
NCT05488418 -
Clinical Study of Biomarkers of Stress Resilience: Role of ELK1 and GPR56
|
N/A | |
Not yet recruiting |
NCT03608449 -
Doing More With Less": Optimizing Psychotherapeutic Services in the Mental Health System
|
N/A | |
Completed |
NCT03400397 -
An Effectiveness Study of the Cool Kids Programme
|
N/A | |
Completed |
NCT00025844 -
Fear Conditioning Using Computer-Generated Virtual Reality
|
N/A | |
Completed |
NCT02579928 -
Ketamine Infusion for Adolescent Depression and Anxiety
|
Phase 4 | |
Completed |
NCT02270073 -
The Process Outcome Mindfulness Effects in Trainees (PrOMET)-Study
|
N/A | |
Terminated |
NCT03764644 -
Web-based Attention Bias Modification Treatment for Childhood Anxiety Disorders
|
N/A | |
Completed |
NCT01721824 -
The Effect of IPS-MA- A Modified Early Supported Employment Intervention for Individuals With Mood or Anxiety Disorders
|
N/A | |
Completed |
NCT01425619 -
The Effect of Medical Clowns and Topical Anesthetic Cream on Pain and Anxiety in Children Undergoing Allergy Skin Tests
|
N/A | |
Completed |
NCT01730625 -
Augmenting Effects of ABMT on CBT in Anxious Children: A Randomized Clinical Trial
|
N/A |